![](/img/cover-not-exists.png)
Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma
Locke, Frederick L., Neelapu, Sattva S., Bartlett, Nancy L., Siddiqi, Tanya, Chavez, Julio C., Hosing, Chitra M., Ghobadi, Armin, Budde, Lihua E., Bot, Adrian, Rossi, John M., Jiang, Yizhou, Xue, AlleVolume:
25
Language:
english
Journal:
Molecular Therapy
DOI:
10.1016/j.ymthe.2016.10.020
Date:
January, 2017
File:
PDF, 579 KB
english, 2017